Syncor Expects Profit to Be Lower Than Projected

Syncor International Corp., a Chatsworth provider of specialty pharmaceuticals, said it expects to report a profit of about $700,000 to $1 million for its second quarter ending June 30, well below analysts’ projections.

The company’s net sales are expected to range from $81 million to $82 million.

A year earlier, Syncor earned $3.1 million from continuing operations on net sales of $59.7 million.

Syncor said its financial results have been hurt by lower prices it adopted because of competition, and its plan to increase its market penetration and market share with certain products.